EKTTITAB has released its financial statements for the second quarter of 2026, officially covering the period ending June 30, 2026.
The provided disclosure is limited to the announcement metadata and does not contain specific figures for net profit, revenue, or year-over-year comparisons.
Because the source text lacks line-item data, specific drivers of performance—such as margins, impairments, or operational expenses—cannot be determined from this summary.
Investors should refer to the full "Financial Statements 30062026.Pdf" attachment for the comprehensive balance sheet and income statement details for the period.